Oxomics’ New Blood-Based Test The First To Identify If A Patient Has Cancer And If It Has SpreadGemma Cann2024-11-28T16:54:08+00:00January 11th, 2022|News|
New Antibiotic Resistance Test Developed By AGPlus DiagnosticsGemma Cann2024-11-28T15:23:59+00:00August 25th, 2021|Colworth Park, News|
Concepta Inks Global License Agreement With Abingdon HealthGemma Cann2024-11-28T15:24:29+00:00August 25th, 2021|Colworth Park, News|
Stream Bio Works With MIP Diagnostics On Rapid Diagnostic And Mass Screening Test For COVID-19Gemma Cann2024-11-28T15:24:51+00:00August 25th, 2021|Colworth Park, News|
Veravas And MIP Diagnostics Announce International Agreement For Improved DiagnosticsGemma Cann2024-11-28T15:25:07+00:00August 25th, 2021|Colworth Park, News|
AgPlus Developing Two Assays To Support The COVID-19 Diagnostic EffortGemma Cann2024-11-28T15:27:12+00:00August 25th, 2021|Colworth Park, News|
MIP Diagnostics Signs Significant Commercial AgreementGemma Cann2022-06-30T12:00:27+01:00August 25th, 2021|Colworth Park, News|
Almac Discovery Expands Disease Focus Into Respiratory DiseaseGemma Cann2024-11-26T12:21:23+00:00July 20th, 2021|Article, Edinburgh Technopole|
